Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Reports Preliminary Fourth Quarter and Full Year 2014 Results

- Fourth Quarter GAAP EPS of $0.29; Non-GAAP Adjusted EPS of $0.50 - - 2015 Revenue Guidance of Between $960 million and $980 million - - 2015 Non-GAAP Adjusted EPS Guidance of $1.88 - $1.98 -...
January 29, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Announces Fourth Quarter 2014 Earnings Release and Conference Call Information

LAKE FOREST, Ill., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), expects to release fourth quarter 2014 earnings before the U.S. equities markets open on Thursday, February 26, 2015. In...
January 20, 2015 07:00 ET | Source: Akorn, Inc.

Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution

LAKE FOREST, Ill., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on the Company's New Drug...
January 15, 2015 17:30 ET | Source: Akorn, Inc.

Akorn Confirms Generic Durezol(R) Patent Challenge

LAKE FOREST, Ill., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration...
December 19, 2014 09:30 ET | Source: Akorn, Inc.

Akorn to Present at the 33rd Annual J.P. Morgan Healthcare Conference

LAKE FOREST, Ill., Dec. 19, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a specialty generic pharmaceutical company, announced today that Raj Rai, Chief Executive Officer, will provide an...
November 06, 2014 07:30 ET | Source: Akorn, Inc.

Akorn Reports Preliminary 2014 Third Quarter Results

LAKE FOREST, Ill., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, today reported preliminary financial results for the fiscal third quarter ended September...
October 21, 2014 11:02 ET | Source: Akorn, Inc.

Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information

LAKE FOREST, Ill., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX) will host a conference call on Thursday, November 6, 2014, to discuss third quarter 2014 results followed by a Q&A...
September 30, 2014 16:15 ET | Source: Akorn, Inc.

Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion

LAKE FOREST, Ill., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, today announced that it has signed a definitive agreement ("Agreement") to acquire...
August 12, 2014 08:50 ET | Source: Akorn, Inc.

Akorn Completes Acquisition of VersaPharm

LAKE FOREST, Ill., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of VPI...
August 05, 2014 06:05 ET | Source: Akorn, Inc.

Akorn Reports Preliminary 2014 Second Quarter Results

LAKE FOREST, Ill., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a niche generic pharmaceutical company, today reported preliminary financial results for the second quarter ended...